Compare, Analyse Sun Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs MYLAN (US) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   MYLAN
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
MYLAN
Dec-18
SUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs4843,487-   
Low Rs3151,919-   
Sales per share (Unadj.) Rs136.91,604.6-  
Earnings per share (Unadj.) Rs17.543.6-  
Cash flow per share (Unadj.) Rs26.0344.0-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs188.71,735.9-  
Shares outstanding (eoy) m2,399.26514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.91.7 173.3%   
Avg P/E ratio x22.962.0 36.9%  
P/CF ratio (eoy) x15.47.9 195.6%  
Price / Book Value ratio x2.11.6 136.0%  
Dividend payout %22.90-   
Avg Mkt Cap Rs m958,8641,390,845 68.9%   
No. of employees `00017.835.0 50.7%   
Total wages/salary Rs m63,6240-   
Avg. sales/employee Rs Th18,490.623,587.6 78.4%   
Avg. wages/employee Rs Th3,582.60-   
Avg. net profit/employee Rs Th2,357.6640.5 368.1%   
INCOME DATA
Net Sales Rs m328,375825,567 39.8%  
Other income Rs m6,3600-   
Total revenues Rs m334,735825,567 40.5%   
Gross profit Rs m69,898213,626 32.7%  
Depreciation Rs m20,528154,579 13.3%   
Interest Rs m3,02739,707 7.6%   
Profit before tax Rs m52,70219,341 272.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,6060-   
Tax Rs m8,228-3,077 -267.4%   
Profit after tax Rs m41,86822,418 186.8%  
Gross profit margin %21.325.9 82.3%  
Effective tax rate %15.6-15.9 -98.1%   
Net profit margin %12.82.7 469.5%  
BALANCE SHEET DATA
Current assets Rs m316,542460,996 68.7%   
Current liabilities Rs m157,064336,117 46.7%   
Net working cap to sales %48.615.1 321.1%  
Current ratio x2.01.4 146.9%  
Inventory Days Days8884 104.7%  
Debtors Days Days10593 112.2%  
Net fixed assets Rs m243,102160,146 151.8%   
Share capital Rs m2,399440 545.8%   
"Free" reserves Rs m450,2450-   
Net worth Rs m452,645893,113 50.7%   
Long term debt Rs m20,289963,955 2.1%   
Total assets Rs m682,5252,395,675 28.5%  
Interest coverage x18.41.5 1,237.9%   
Debt to equity ratio x01.1 4.2%  
Sales to assets ratio x0.50.3 139.6%   
Return on assets %6.62.6 253.7%  
Return on equity %9.22.5 368.5%  
Return on capital %11.23.2 353.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m46,2550-   
CASH FLOW
From Operations Rs m65,548171,553 38.2%  
From Investments Rs m-25,888-88,674 29.2%  
From Financial Activity Rs m-57,151-79,919 71.5%  
Net Cashflow Rs m-13,8571,421 -975.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.26 Rs / USD

Compare SUN PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: AUROBINDO PHARMA  VENUS REMEDIES  STRIDES PHARMA SCIENCE  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Revealing at 5pm Today: The Great Indian Wealth Project
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


May 17, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 5-YR ANALYSIS

COMPARE SUN PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS